Pure Global

Face Masks to Reduce SARS-CoV-2 Infections (COVID-19) in Bangladesh - Trial NCT05197725

Access comprehensive clinical trial information for NCT05197725 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Withdrawn. The study focuses on Covid19. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05197725
Withdrawn
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05197725
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Face Masks to Reduce SARS-CoV-2 Infections (COVID-19) in Bangladesh
Face Masks to Reduce Symptomatic and Asymptomatic SARS-CoV-2 Infections in Bangladesh

Study Focus

Covid19

Face mask

Interventional

device

Sponsor & Location

Yale University

Dhaka, Bangladesh

Timeline & Enrollment

N/A

Feb 04, 2023

May 30, 2023

0 participants

Primary Outcome

Asymptomatic and asymptomatic SARS-CoV-2 infection

Summary

The primary goal of the village-level intervention is to assess whether mask-wearing reduces
 community-level asymptomatic and symptomatic SARS-CoV-2 infections, assessed via PCR testing.
 The study also examines if community-based activation through values or individual activation
 through information results in higher mask-wearing.

ICD-10 Classifications

COVID-19, virus identified
COVID-19, virus not identified
Coronavirus infection, unspecified site
Rift Valley fever
Plague

Data Source

ClinicalTrials.gov

NCT05197725

Device Trial